Inflammation-Induced Vasoconstrictor Hyporeactivity Is Caused by Oxidative Stress

Journal of the American College of Cardiology

Volumn 42, Issue 9, 2003, Pages 1656-1662

  Pleiner, Johannes ^a   Mittermayer, Friedrich ^a   Schaller, Georg ^a   Marsik, Claudia ^a   MacAllister, Raymond J ^b   Wolzt, Michael ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANTIOXIDANT; ASCORBIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; CATECHOLAMINE DERIVATIVE; ESCHERICHIA COLI ENDOTOXIN; NORADRENALIN; VASOCONSTRICTOR AGENT; VASOPRESSIN;

ACUTE DISEASE; ADULT; ARTICLE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDOTOXEMIA; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION;

EID: 0242460460     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.06.002     Document Type: Article

References (37)

1. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
2. Pleiner J, Heere-Ress E, Langenberger H, et al. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 2002;22:95-100.
3. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 2000;97: 9753-8.
4. Babior BM. The respiratory burst oxidase. Adv Enzymol Relat Areas Mol Biol 1992;65:49-95.
5. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1998;320:1165-72.
6. Pernerstorfer T, Hollenstein U, Hansen J, et al. Heparin blunts endotoxin-induced coagulation activation. Circulation 1999;100: 2485-90.
7. Hokanson DE, Sumner DS, Strandness DE. An electrically calibrated plethysmograph for direct measurement of limb blood flow. Trans Biomed Eng 1975;22:21-4.
8. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25:918-23.
9. Pleiner J, Mittermayer F, Schaller G, MacAllister RJ, Wolzt M. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 2002;106: 1460-4.
10. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97: 22-8.
11. Vandivier RW, Eidsath A, Banks SM, et al. Down-regulation of nitric oxide production by ibuprofen in human volunteers. J Pharmacol Exp Ther 1999;289:1398-403.
12. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995;41: 892-6.
13. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997;25:1095-100.
14. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-59.
15. Annane D, Sanquer S, Sebille V, et al. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000;355:1143-8.
16. Wray GM, Coakley JH. Severe septic shock unresponsive to noradrenaline. Lancet 1995;346:1604.
17. Thomas VL, Nielsen MS. Administration of angiotensin II in refractory septic shock. Crit Care Med 1991;19:1084-6.
18. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001;29:487-93.
19. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-10.
20. Dünser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-9.
21. Schaller MD, Waeber B, Nussberger J, Brunner HR. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol 1985;249:H1086-92.
22. Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension 2001;38:177-82.
23. Hollenberg SM, Tangora JJ, Piotrowski MJ, Easington C, Parillo JE. Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Crit Care Med 1997;25:869-73.
24. Zhong J, Hwang TC, Adams HR, Rubin LJ. Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am J Physiol 1997;273:H2312-24.
25. 2+ of aortic smooth muscle in endotoxin-treated rats: NO-dependent and -independent in vitro mechanisms. Res Commun Mol Pathol Pharmacol 1996;92:275-84.
26. Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 2001;29:2185-93.
27. Stoclet JC, Martinez MC, Ohlmann P, et al. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 1999;100:107-12.
28. Bhagat K, Collier J, Vallance P. Local venous responses to endotoxin in humans. Circulation 1996;94:490-7.
29. Jackson TS, Xu A, Vita JA, Keaney JF. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998;83:916-22.
30. Victor VV, Guayerbas N, Puerto M, Medina S, De la Fuente M. Ascorbic acid modulates in vitro the function of macrophages from mice with endotoxic shock. Immunopharmacology 2000;46:89-101.
31. 2, HOONO). Eur J Biochem 1998;253:146-53.
32. 2 radical reaction. Eur J Biochem 1999;265:967-71.
33. Whiteman M, Halliwell B. Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid: a comparison with other biological antioxidants. Free Radic Res 1996;25:275-83.
34. Kirsch M, de Groot H. Ascorbate is a potent antioxidant against peroxynitrite-induced oxidation reactions. Evidence that ascorbate acts by re-reducing substrate radicals produced by peroxynitrite. J Biol Chem 2000;275:16702-8.
35. Suzuki S, Takeshita A, Imaizumi T, et al. Biphasic forearm vascular responses to intraarterial arginine vasopressin. J Clin Invest 1989;84: 427-34.
36. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med 2002;30:S64-73.
37. van der Poll T, Coyle SM, Moldawer LL, Lowry SF. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J Infect Dis 1996;174:1356-60.